Valtrate

DB20889ExperimentalSmall molecule

Valtrate is a small molecule drug. Valtrate has a monoisotopic molecular weight of 422.19 Da.

Mechanism: Pharmacologically active on Signal transducer and activator of transcription 3, Exportin-1, and Protein Rev
Curator reviewed
Formula / weight: C₂₂H₃₀O₈ · 422.474 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyBDIAUFOIMFAIPU-KVJIRVJXSA-NSMILES[H][C@]12[C@H](OC(=O)CC(C)C)OC=C(COC(C)=O)C1=C[C@H](OC(=O)CC(C)C)[C@]21CO1

Targets

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Valtrate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.